Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer.
Bartenbaker Thompson A, Sutcliffe EG, Arvai K, Roberts ME, Susswein LR, Marshall ML, Torene R, Vogel Postula KJ, Hruska KS, Bai S.
Fam Cancer. 2022 Jan 4. doi: 10.1007/s10689-021-00285-7. Epub ahead of print.
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.
Hovland HN, Al-Adhami R, Ariansen SL, Van Ghelue M, Sjursen W, Lima S, Bolstad M, Berger AH, Høberg-Vetti H, Knappskog P, Haukanes BI, Aukrust I, Ognedal E.
Fam Cancer. 2022 Jan 4. doi: 10.1007/s10689-021-00286-6. Epub ahead of print.
The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study.
Bouferraa Y, Haibe Y, Chedid A, Jabra E, Charafeddine M, Temraz S, Mukherji D, El Saghir N, Shamseddine A.
BMC Cancer. 2022 Jan 3;22(1):27. doi: 10.1186/s12885-021-09100-z.